tazarotene has been researched along with Facial Dermatoses in 7 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
Facial Dermatoses: Skin diseases involving the FACE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A multicenter, investigator-masked, randomized, parallel-group study was performed in 440 patients with mild-to-moderate facial acne vulgaris to compare the efficacy and tolerability of tazarotene monotherapy with 3 combination regimens--tazarotene plus benzoyl peroxide gel, tazarotene plus erythromycin/benzoyl peroxide gel, and tazarotene plus clindamycin phosphate lotion." | 9.10 | Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy. ( Draelos, ZD; Tanghetti, EA, 2002) |
| "Tazarotene treatment was associated with a significantly greater incidence of treatment success (defined as > or = 50% global improvement [67% vs 49%; P=." | 6.70 | Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial. ( Berson, D; Lee, J; Leyden, JJ; Miller, B; Tanghetti, EA; Ung, M, 2002) |
| "In this multicentre, double-blind, randomized, vehicle-controlled study, 50 patients with photodamaged facial skin (at least mild fine wrinkling and mottled hyperpigmentation, with at least one of these being moderate) were randomized to apply tazarotene 0." | 5.11 | Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin. ( Holland, JM; Kaidbey, K; Lim, J; Loven, KH; Machtinger, LA; Parizadeh, DD; Rist, TE; Sefton, J; Walker, PS; Wilson, DC, 2004) |
| "A total of 568 patients with at least moderate fine wrinkling or mottled hyperpigmentation applied tazarotene 0." | 5.11 | A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage. ( Gibson, JR; Kang, S; Krueger, GG; Lew-Kaya, D; Sefton, J; Tanghetti, EA; Walker, PS, 2005) |
| "A multicenter, investigator-masked, randomized, parallel-group study was performed in 440 patients with mild-to-moderate facial acne vulgaris to compare the efficacy and tolerability of tazarotene monotherapy with 3 combination regimens--tazarotene plus benzoyl peroxide gel, tazarotene plus erythromycin/benzoyl peroxide gel, and tazarotene plus clindamycin phosphate lotion." | 5.10 | Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy. ( Draelos, ZD; Tanghetti, EA, 2002) |
| "Tazarotene treatment was associated with a significantly greater incidence of treatment success (defined as > or = 50% global improvement [67% vs 49%; P=." | 2.70 | Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial. ( Berson, D; Lee, J; Leyden, JJ; Miller, B; Tanghetti, EA; Ung, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Machtinger, LA | 1 |
| Kaidbey, K | 1 |
| Lim, J | 1 |
| Loven, KH | 1 |
| Rist, TE | 1 |
| Wilson, DC | 1 |
| Parizadeh, DD | 1 |
| Sefton, J | 2 |
| Holland, JM | 1 |
| Walker, PS | 2 |
| Kang, S | 1 |
| Krueger, GG | 1 |
| Tanghetti, EA | 3 |
| Lew-Kaya, D | 1 |
| Gibson, JR | 1 |
| Rallis, E | 1 |
| Karanikola, E | 1 |
| Verros, C | 1 |
| Draelos, ZD | 1 |
| Leyden, JJ | 1 |
| Miller, B | 1 |
| Ung, M | 1 |
| Berson, D | 1 |
| Lee, J | 2 |
| Webster, GF | 1 |
| Guenther, L | 1 |
| Poulin, YP | 1 |
| Solomon, BA | 1 |
| Loven, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Safety and Efficacy of Tazarotene 0.1% Plus Clindamycin 1% Gel vs. Adapalene 0.1% Plus Clindamycin 1% Gel in the Treatment of Facial Acne Vulgaris: A Randomized Controlled Trial[NCT02721173] | Phase 4 | 60 participants (Actual) | Interventional | 2016-04-30 | Completed | ||
| Microneedling Versus Topical Tazarotene 0.1% Gel for the Treatment of Atrophic Post Acne Scarring - a Randomized Controlled Study[NCT03170596] | 36 participants (Actual) | Interventional | 2017-06-02 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for tazarotene and Facial Dermatoses
| Article | Year |
|---|---|
Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin.
Topics: Adult; Aged; Double-Blind Method; Facial Dermatoses; Female; Humans; Hyperpigmentation; Keratinocyte | 2004 |
A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
Topics: Adult; Aged; Aged, 80 and over; Dermatologic Agents; Double-Blind Method; Facial Dermatoses; Female; | 2005 |
Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide | 2002 |
Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Child; Cost-Benefit Analysis; Dermatolo | 2002 |
A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Child; Cost-Benefit Analysis | 2002 |
2 other studies available for tazarotene and Facial Dermatoses
| Article | Year |
|---|---|
Acne cream can reverse sun damage.
Topics: Dermatologic Agents; Facial Dermatoses; Humans; Nicotinic Acids; Sunlight | 2003 |
Successful treatment of Favre-Racouchot disease with 0.05% tazarotene gel.
Topics: Administration, Cutaneous; Adult; Aged; Dermatologic Agents; Diagnosis, Differential; Facial Dermato | 2007 |